Daniel Gall, PhD, is a Principal Scientist in Biologics Analytical R&D at AbbVie, where they guide antibody and adeno-associated virus (AAV) gene therapy analytics through various stages of development. They have 20 years of experience in the pharmaceutical and bioenergy industries, emphasizing enzyme catalysis and metabolism research. Previously, Daniel held positions at KBI Biopharma and PTC Therapeutics, where they led analytical method development and coordinated cross-departmental initiatives. Daniel earned a PhD in Biotechnology from the University of Wisconsin-Madison, contributing to multiple publications and patents during their academic career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices